We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00517803
First Posted: August 17, 2007
Last Update Posted: August 28, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Lawson Health Research Institute
  Purpose

We hypothesize that micronutrient fortified probiotic yogurt can improve nutritional status and enhance immunity parameters in subjects HIV/AIDS and other immunodeficiencies.

We have developed a micronutrient-fortified probiotic yogurt that has safe and beneficial levels of micronutrients for human consumption. This has been undertaken with the guidance of Edward Farnworth, a senior research scientist at Agri-Food Canada-Food Research and Development Centre, St. Hyacinthe, Quebec

We will now measure nutritional parameters (height, weight, serum albumin, serum nutrient levels, blood urea, liver function tests (AST, ALT)) to determine if there is a statistically significant difference between the various levels of fortified probiotic yogurt and the placebo on the nutritional parameters of the subjects consuming the yogurt.

We will measure immunological parameters (CD4 lymphocyte count, CBC, levels of TNFα, IL-12, IL-10, and G-CSF [Kim, et.al. 2006]) in order to determine if there is a statistically significant difference using fortified probiotic yogurt compared to a placebo.

In addition, we will determine if the micronutrient-fortified probiotic yogurt has a significant impact on the overall quality of life for the subjects using the "linear analogue self assessment" tool [Kaiser, et.al 2006].


Condition Intervention
HIV Infections Cancer, Second Primary Dietary Supplement: Probiotic Yogurt B: with various micronutrients Dietary Supplement: Probiotic Yogurt A: Kaiser micronutrients Dietary Supplement: Probiotic yogurt C: with basic micronutrients Dietary Supplement: Probiotic Yogurt D: Placebo -- no added micronutrients

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Supportive Care
Official Title: Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies: A Randomized, Placebo-controlled Trial

Resource links provided by NLM:


Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Statistically significant improvement of immune status (CD4) Statistically significant improvement of nutritional status [ Time Frame: Baseline and Follow-up for each yogurt type ]

Secondary Outcome Measures:
  • Improved quality of life [ Time Frame: 4 months ]

Enrollment: 24
Actual Study Start Date: September 7, 2007
Study Completion Date: March 2, 2009
Primary Completion Date: March 2, 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Dietary Supplement: Probiotic Yogurt B: with various micronutrients
175g probiotic yogurt / day 25% RDA for each nutrient
Dietary Supplement: Probiotic Yogurt A: Kaiser micronutrients
175g probiotic yogurt/ day 25% RDA for each nutrient
Dietary Supplement: Probiotic yogurt C: with basic micronutrients
175g yogurt/ day 25% RDA for each nutrient
Placebo Comparator: 2 Dietary Supplement: Probiotic Yogurt D: Placebo -- no added micronutrients
175g/day probiotic yogurt

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Clinically tested CD4 lymphocyte count between 200-400cells/mL (HIV population)
  • Confirmed cancer by physician (cancer population)
  • Confirmed HIV by physician (HIV population)

Exclusion Criteria:

  • Opportunistic infection
  • Mental illness impairing ability to comply with study
  • Pregnancy
  • Currently consuming micronutrient supplement or probiotic
  • Clinical history of lactose-intolerance or cow's milk allergies
  • Require surgery, radiation or chemotherapy during the study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00517803


Locations
Canada, Ontario
St. Joseph's Hospital
London, Ontario, Canada, N6A 4V2
Sponsors and Collaborators
Lawson Health Research Institute
Investigators
Principal Investigator: Gregor Reid, PhD Lawson Health Research Institute
  More Information

Publications:
Hekmat, S & Reid, G. 2006 The survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in milk. International Journal of Food Science and Technology (in press).

Responsible Party: Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00517803     History of Changes
Other Study ID Numbers: R-07-220
13468
First Submitted: August 16, 2007
First Posted: August 17, 2007
Last Update Posted: August 28, 2017
Last Verified: August 2017

Keywords provided by Lawson Health Research Institute:
micronutrients
immunodeficiency
probiotics
yogurt
Healthy
Acquired Immunodeficiency Syndrome
Complementary Therapies

Additional relevant MeSH terms:
HIV Infections
Immunologic Deficiency Syndromes
Neoplasms, Second Primary
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immune System Diseases
Neoplasms
Micronutrients
Trace Elements
Growth Substances
Physiological Effects of Drugs